|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Freitas AC, Gurgel AP, Chagas BS,
Coimbra EC and do Amaral CM: Susceptibility to cervical cancer: An
overview. Gynecol Oncol. 126:304–311. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wani K and Nair CK: Genetic alterations in
cervical cancer. Indian J Exp Biol. 41:789–796. 2003.PubMed/NCBI
|
|
4
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jiang J, Yan M, Mehta JL and Hu C:
Angiogenesis is a link between atherosclerosis and tumorigenesis:
Role of LOX-1. Cardiovasc Drugs Ther. 25:461–468. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
De Palma M, Biziato D and Petrova TV:
Microenvironmental regulation of tumour angiogenesis. Nat Rev
Cancer. 17:457–474. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nyberg P, Salo T and Kalluri R: Tumor
microenvironment and angiogenesis. Front Biosci. 13:6537–6553.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Folkman J and Shing Y: Angiogenesis. J
Biol Chem. 267:10931–10934. 1992.PubMed/NCBI
|
|
9
|
Chung AS and Ferrara N: Developmental and
pathological angiogenesis. Annu Rev Cell Dev Biol. 27:563–584.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fujimoto J, Sakaguchi H, Aoki I and Tamaya
T: Clinical implications of expression of interleukin 8 related to
angiogenesis in uterine cervical cancers. Cancer Res. 60:2632–2635.
2000.PubMed/NCBI
|
|
11
|
López-Ocejo O, Viloria-Petit A,
Bequet-Romero M, Mukhopadhyay D, Rak J and Kerbel RS: Oncogenes and
tumor angiogenesis: The HPV-16 E6 oncoprotein activates the
vascular endothelial growth factor (VEGF) gene promoter in a p53
independent manner. Oncogene. 19:4611–4620. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu YJ, Soumelis V, Watanabe N, Ito T,
Wang YH, Malefyt Rde W, Omori M, Zhou B and Ziegler SF: TSLP: An
epithelial cell cytokine that regulates T cell differentiation by
conditioning dendritic cell maturation. Annu Rev Immunol.
25:193–219. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sokol CL, Barton GM, Farr AG and Medzhitov
R: A mechanism for the initiation of allergen-induced T helper type
2 responses. Nat Immunol. 9:310–318. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rochman Y and Leonard WJ: Thymic stromal
lymphopoietin: A new cytokine in asthma. Curr Opin Pharmacol.
8:249–254. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu YJ: Thymic stromal lymphopoietin and
OX40 ligand pathway in the initiation of dendritic cell-mediated
allergic inflammation. J Allergy Clin Immunol. 120:238–246. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Park LS, Martin U, Garka K, Gliniak B, Di
Santo JP, Muller W, Largaespada DA, Copeland NG, Jenkins NA, Farr
AG, et al: Cloning of the murine thymic stromal lymphopoietin
(TSLP) receptor: Formation of a functional heteromeric complex
requires interleukin 7 receptor. J Exp Med. 192:659–670. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Reche PA, Soumelis V, Gorman DM, Clifford
T, Liu Mr, Travis M, Zurawski SM, Johnston J, Liu YJ, Spits H, et
al: Human thymic stromal lymphopoietin preferentially stimulates
myeloid cells. J Immunol. 167:336–343. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xie F, Meng YH, Liu LB, Chang KK, Li H, Li
MQ and Li DJ: Cervical carcinoma cells stimulate the angiogenesis
through TSLP promoting growth and activation of vascular
endothelial cells. Am J Reprod Immunol. 70:69–79. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xie F, Liu LB, Shang WQ, Chang KK, Meng
YH, Mei J, Yu JJ, Li DJ and Li MQ: The infiltration and functional
regulation of eosinophils induced by TSLP promote the proliferation
of cervical cancer cell. Cancer Lett. 364:106–117. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Davis BP and Rothenberg ME: Eosinophils
and cancer. Cancer Immunol Res. 2:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Facciabene A, Peng X, Hagemann IS, Balint
K, Barchetti A, Wang LP, Gimotty PA, Gilks CB, Lal P, Zhang L and
Coukos G: Tumour hypoxia promotes tolerance and angiogenesis via
CCL28 and T(reg) cells. Nature. 475:226–230. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cormier SA, Taranova AG, Bedient C, Nguyen
T, Protheroe C, Pero R, Dimina D, Ochkur SI, O'Neill K, Colbert D,
et al: Pivotal advance: Eosinophil infiltration of solid tumors is
an early and persistent inflammatory host response. J Leukoc Biol.
79:1131–1139. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ayhan A, Altintaş A, Tuncer ZS, Küçükali T
and Yüce K: Prognostic value of mitotic activity, eosinophilic and
inflammatory reaction in stage I cancer of the uterine cervix. Eur
J Surg Oncol. 18:264–266. 1992.PubMed/NCBI
|
|
24
|
Lotfi R, Lee JJ and Lotze MT: Eosinophilic
granulocytes and damage-associated molecular pattern molecules
(DAMPs): Role in the inflammatory response within tumors. J
Immunother. 30:16–28. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stone KD, Prussin C and Metcalfe DD: IgE,
mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 125
2 Suppl 2:S73–S80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pretlow TP, Keith EF, Cryar AK, Bartolucci
AA, Pitts AM, Pretlow TG II, Kimball PM and Boohaker EA: Eosinophil
infiltration of human colonic carcinomas as a prognostic indicator.
Cancer Res. 43:2997–3000. 1983.PubMed/NCBI
|
|
27
|
Caruso RA, Parisi A, Quattrocchi E,
Scardigno M, Branca G, Parisi C, Lucianò R, Paparo D and Fedele F:
Ultrastructural descriptions of heterotypic aggregation between
eosinophils and tumor cells in human gastric carcinomas.
Ultrastruct Pathol. 35:145–149. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Horiuchi K, Mishima K, Ohsawa M, Sugimura
M and Aozasa K: Prognostic factors for well-differentiated squamous
cell carcinoma in the oral cavity with emphasis on
immunohistochemical evaluation. J Surg Oncol. 53:92–96. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hanahan D and Folkman J: Patterns and
emerging mechanisms of the angiogenic switch during tumorigenesis.
Cell. 86:353–364. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Carmeliet P: Angiogenesis in life, disease
and medicine. Nature. 438:932–936. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Folkman J and Kalluri R: Cancer without
disease. Nature. 427:7872004. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ruhrberg C: Growing and shaping the
vascular tree: Multiple roles for VEGF. Bioessays. 25:1052–1060.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sulpice E, Ding S, Muscatelli-Groux B,
Bergé M, Han ZC, Plouet J, Tobelem G and Merkulova-Rainon T:
Cross-talk between the VEGF-A and HGF signalling pathways in
endothelial cells. Biol Cell. 101:525–539. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cross MJ and Claesson-Welsh L: FGF and
VEGF function in angiogenesis: Signalling pathways, biological
responses and therapeutic inhibition. Trends Pharmacol Sci.
22:201–207. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Puxeddu I, Alian A, Piliponsky AM, Ribatti
D, Panet A and Levi-Schaffer F: Human peripheral blood eosinophils
induce angiogenesis. Int J Biochem Cell Biol. 37:628–636. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Munitz A and Levi-Schaffer F: Eosinophils:
‘New’ roles for ‘old’ cells. Allergy. 59:268–275. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Salcedo R, Young HA, Ponce ML, Ward JM,
Kleinman HK, Murphy WJ and Oppenheim JJ: Eotaxin (CCL11) induces in
vivo angiogenic responses by human CCR3+ endothelial
cells. J Immunol. 166:7571–7578. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Efraim Nissim Ben AH, Eliashar R and
Levi-Schaffer F: Hypoxia modulates human eosinophil function. Clin
Mol Allergy. 8:102010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Porter LM, Cowburn AS, Farahi N, Deighton
J, Farrow SN, Fiddler CA, Juss JK, Condliffe AM and Chilvers ER:
Hypoxia causes IL-8 secretion, Charcot Leyden crystal formation,
and suppression of corticosteroid-induced apoptosis in human
eosinophils. Clin Exp Allergy. 47:770–784. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Temkin V, Aingorn H, Puxeddu I, Goldshmidt
O, Zcharia E, Gleich GJ, Vlodavsky I and Levi-Schaffer F:
Eosinophil major basic protein: First identified natural
heparanase-inhibiting protein. J Allergy Clin Immunol. 113:703–709.
2004. View Article : Google Scholar : PubMed/NCBI
|
